Antiphospholipid syndrome can have various clinical presentations, two of the most common being arterial and venous thrombosis. It is, however, unusual for them to occur in combination. We report here a case of combined hepatic artery and segmental portal venous occlusion in a 32-year-old patient who was shown to have a lupus anticoagulant. There have been no previous reports of thrombosis occurring simultaneously in the coeliac axis and the portal vein. Computerised tomography, Doppler ultrasound scanning and selective visceral angiography were used to demonstrate the anatomical lesions. The patient was treated medically with unfractionated heparin leading to a favourable clinical outcome. The diagnosis and management of this case is discussed with reference to the current literature on visceral thrombosis and antiphospholipid antibody syndrome.

1.
England RJ, Woodcock B, Zeiderman MR: Superior mesenteric artery thrombosis in a patient with antiphospholipid syndrome. Eur J Vasc Endovasc Surg 1995;10:372–373.
2.
Hull RG, Harris EN, Gharavi AE, Tincani A, Asherson RA, Valesini G, Denman AM, Froude G, Hughes GR: Anticardiolipin antibodies: occurrence in Behcet’s synrome. Ann Rheum Dis 1984;43:746–748.
3.
Nussaume O, Bouttier S, Duchatelle JP, Valere PE, Andreassian B: Mesenteric infarction in Takayasu’s disease. Ann Vasc Surg 1990;4:117–121.
4.
Lamy AL, Roy PH, Morissette JJ, Cantin R: Intimal hyperplasia and thrombosis of the visceral arteries in a young woman: Possible relation with oral contraceptives and smoking. Surgery 1988;103:706–710.
5.
Triplett DA: Lupus anticoagulants and thrombosis; in Poller L, Thomson JM (eds): Thrombosis and Its Management. Edinburgh, Churchill Livingstone, 1993, pp 98–112.
6.
Cohen H, McNally T, Dave M, Mackie IJ, Machin SJ: Antibodies to β2-glycoprotein-1 as a marker for thrombosis. Br J Haematol 1995;89:7.
7.
Triplett DA: Developments in antiphospholipid-protein antibodies. Recent Adv Blood Coag 1997;7:19–31.
8.
Min AD, Atillasoy EO, Schwartz ME, Thiim M, Miller CM, Bodenheimer HC Jr: Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transplant Surg 1997;3:423–429.
9.
Ng KF, Lo JW: The development of hypercoagulability state, as measured by thrombelastography, associated with intraoperative surgical blood loss. Anaesth Intensive Care 1996;24:20–25.
10.
Honda K, Ootani K, Inoue S, Nishishita C, Mizuno M, Kato K, Kamoi R, Hoshika K, Iida M, Yoshida K, Shimizu M: Acute superior mesenteric artery thrombosis due to stress erythrocytosis (in Japanese). Nippon Shokakibyo Gakkai Zasshi 1996;93:357–361.
11.
Baker WF, Bick RL: Antiphospholipid antibodies in coronary artery disease: A review. Semin Thromb Hemost 1994;20:27–45.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.